HOYA apologizes for any inconvenience this may cause.

HOYA Surgical Optics is focused on helping ophthalmic surgeons confidently build their premium practices and believes that every patient is a premium patient. These lenses are an important addition to HSO’s line of foldable and pre‐loaded IOL’s available with the Optimized Aspheric™ design. Jake Vander Zanden, President, Americas stated “HOYA Surgical Optics remains strongly committed to our U.S. customers and delivering on this new direction in refractive cataract surgery. Our COMPLETE SYSTEM™ uses the HOYA iTrace® Surgical Workstation with advanced wavefront diagnostics to assist surgeons in the proper selection of an IOL, based on the patient’s specific optical system.”

This approval is another first in the US ophthalmology marketplace. HOYA Surgical Optics is the only company offering both UV Absorbing (clear) and Blue Light Filtering (yellow) IOL’s in preloaded and cartridge style configurations. Any customers in need of assistance are asked to contact their Sales Representative or call Hoya Surgical Optics Customer Service toll‐free at 866‐750‐5870.

About HOYA Surgical Optics
HOYA Surgical Optics is a leading global ophthalmic device company with an entrepreneurial spirit focused on what matters most to realize both exceptional patient outcomes and better practice results. Leveraging more than 70 years of excellence in optics design and innovation that has been the hallmark of the HOYA Corporation, HOYA Surgical Optics provides ophthalmologists with innovative ophthalmic devices and services in key strategic segments that help them elevate their quality of care and business efficiencies.

All statements in this press release that are not statements of historical fact are forward‐looking statements, including statements about any of the following: the plans, strategies, and objectives of management for future operations or prospects for achieving such plans; our future performance statement of belief, and any statements of assumptions underlying any of the foregoing.

“We are very pleased to launch this fully integrated system of advanced diagnostics and IOL. Finally, cataract surgeons have a surgical planning tool that integrates ALL of the information needed in one test, coupled with the most advanced preloaded IOL available in the U.S.,” said Jake Vander Zanden, President, Americas for HOYA Surgical Optics.

The pre-­‐loaded iSert® IOL inserter provides ultimate sterility and control. The HOYA iSert 231 is a hydrophobic IOL with renowned HOYA optics, pre-loaded in the most advanced small-incision insertion system available. It requires only a true 2.4 mm incision and, as a single-use device, iSert reduces the risk of infection in the surgical environment. The Aspheric Balanced Curve technology (ABC design) compensates for decentration and reduces spherical aberration. “Tracey Technologies is pleased to work with HOYA to co-develop the newest generation of iTrace, and producing this full-featured device as a complement to HOYA’s outstanding tools for the cataract surgeon” said Joe Wakil, M.D., CEO of Tracey Technologies. Originally developed as part of missile defense systems, ray-tracing is an incredible technology that has been further advanced through the cooperative R&D efforts of HOYA and Tracey Technologies. The HOYA iTrace Surgical Workstation is the only complete diagnostic device based on advanced ray tracing technology that isolates and quantifies corneal versus lens aberrations. The precise pre-operative metrics that it provides allow surgeons to more accurately predict post-surgery outcomes and select the best IOL for each patient. Dr. David F. Chang, a clinical professor of ophthalmology at the University of California, San Francisco commented, “For a premium refractive IOL practice, this is invaluable technology. The HOYA iTrace Surgical Workstation provides me with all the important preoperative optical information that I need to make an IOL recommendation for the patient. With iTrace, I can immediately rule out some multifocal candidate’s IOL options because of corneal aberrations that would increase the risk of 20/unhappy.”

The 5-in-1 System (Corneal Topographer, Auto-refractor, Wavefront Analyzer, Pupillometer, and Keratometer) also dramatically streamlines patient workups and improves overall office efficiency. Used in combination, these tools provide a patient-centric approach to visual restoration that combines leading technologies and services to deliver the best outcomes for the patient and the practice.

About HOYA Surgical Optics HOYA Surgical Optics is a leading global ophthalmic device company with an entrepreneurial spirit focused on what matters most to realize both exceptional patient outcomes and better practice results. Leveraging more than 70 years of excellence in optics design and innovation that has been the hallmark of the HOYA Corporation, HOYA Surgical Optics provides ophthalmologists with innovative ophthalmic devices and services that help them elevate their quality of care and business efficiencies. For more information, contact HOYA Surgical Optics at 14768 Pipeline Ave., Chino Hills, CA 91709, call 909-680-3900.

About Tracey Technologies, Corp. Tracey Technologies, Corp. is a developer and manufacturer of technologically advanced refractive diagnostic devices. Based in Houston, Texas, Tracey Technologies has produced devices integrating ray tracing aberrometry wavefront analysis with advanced corneal topography analysis for a decade, with the iTrace™ series of products offered since 2008. Tracey Technologies’ patented ray tracing technology, widely viewed as the next generation of refractive diagnostics and the best method for analyzing visual function, is becoming the new standard of care. For more information, visit the company’s Web site at http://www.traceytechnologies.com

In describing the strong business results, Thomas A. Dunlap, President and CEO of HOYA Surgical Optics, said: “We are very pleased with the strong performance of our business in all regions of the world. We have been a leading IOL manufacturer for many years but are still a newcomer to many markets around the world. Our performance this past year demonstrates ophthalmologists’ increasing appreciation for the quality of our IOLs and the confidence they have in achieving exceptional patient outcomes with our lenses. Our year over year revenue growth translates to HOYA being the fastest growing IOL company,” Dunlap added.

Commenting on the Global Optimization plan and headquarter relocation, Mr. Dunlap said: “This plan represents our on-going effort to fully leverage our strengths and operate more consistently as one global organization both internally and externally. We have had a state-of-the-art manufacturing facility in Singapore since 2003 and the integration of key functions at this location will enhance our operational efficiency and bring us closer to customers in important emerging markets.” Mr. Dunlap confirmed that HOYA Surgical Optics will maintain its current offices in the U.S., Japan, and Germany in order to optimize interaction with customers on a local level. “As our business has grown and become more globally integrated, the advantages of operating more uniformly out of a single location became a more obvious competitive advantage,” said Mr. Dunlap.

About HOYA Surgical Optics
HOYA Surgical Optics is a leading global ophthalmic device company with an entrepreneurial spirit focused on what matters most to realize both exceptional patient outcomes and better practice results. Leveraging more than 60 years of excellence in optics design and innovation that has been the hallmark of the HOYA Corporation, HOYA Surgical Optics provides ophthalmologists with innovative ophthalmic devices and services in key strategic segments that help them to elevate their quality of care and business efficiencies.

About HOYA Corporation
HOYA Corporation is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. HOYA is active in four fields of business: The Eye Care provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surgery. The Life Care provides endoscopic systems. Electro-Optics makes mask blanks for photomasks for the semiconductor devised an LCD panels, optical lenses for digital cameras, and glass memory disks for HDD. The Imaging produces SLR/compact digital camera, interchangeable lenses, lens modules, and microlenses. HOYA now has over 100 subsidiaries and affiliates, and employs approximately 38,000 people worldwide.

All statements in this press release that are not statements of historical fact are forward looking statements, including statements about any of the following: the plans, strategies, and objectives of management for future operations or prospects for achieving such plans; our future performance statement of belief; and any statements of assumptions underlying any of the foregoing.

CHINO HILLS, CALIF., August 13, 2009—Hoya Surgical Optics, Inc., announced today the United States introduction of the iSert™ Preloaded Intraocular Lens (IOL) Injection System. The iSert’s™ revolutionary technology provides unparalleled predictability and safety for intraocular lens insertion. With the IOL already loaded and ready for insertion, the system eliminates the potential for lens damage due to misloading and risk of contamination from endotoxins associated with reusable instruments.

“Frequently, there is a lot of pressure to load lenses quickly without errors during ophthalmic surgery,” says Joseph Russell, Vice President of Sales and Marketing, Hoya Surgical Optics. “With iSert™, the lens arrives already loaded into the inserter, eliminating lens handling prior to implantation. The iSert™ can be readied for the surgeon in about 15 seconds, even in the dim light of the O.R. This simple preparation ensures predictability and eliminates risk associated with damaged lenses or contamination. iSert™ can dramatically improve patient safety and efficiency in the O.R., while allowing the staff to concentrate on the most important part of the surgery—the patient—and not the IOL and inserter.”

The iSert™ Preloaded System is a proven technology. In use in Europe and Japan since 2007, the iSert™ Preloaded System’s completely closed system—from manufacturing facility to implantation in the eye—delivers a lens that is untouched by human hands for the ultimate in safety and sterility. The single-use inserter eliminates the risk of contamination from endotoxins associated with reusable materials and weaknesses of flash sterilization that can result in toxic anterior segment syndrome (TASS).

In addition, doctors can utilize the glistening-free, hydrophobic acrylic aspheric Hoya Surgical Optics lenses introduced earlier this year with the advanced technology of the iSert™ Preloaded IOL System. The iSert™ bevel tip is designed to accommodate surgeons who prefer incisions smaller than 2.4- mm.

“As the first IOL manufacturer to provide a preloaded lens insertion system into the United States, we are excited about creating a major paradigm shift in cataract surgery,” says Tom Dunlap, president and CEO. “The team at Hoya Surgical Optics will continue to provide surgeons with the most advanced ophthalmic technologies that allow them to deliver safer, better vision results for patients.”

About Hoya Surgical Optics
Hoya Surgical Optics is a global company focused on meeting the needs of surgeons and patients worldwide. As the world’s fourth largest IOL manufacturer and distributor, we are deeply committed to advancing ophthalmic surgery by combining surgeons’ clinical and professional knowledge with our optics research and development. Leveraging more than 60 years of excellence in optics design and innovation that has been the benchmark of the Hoya Corporation, Hoya Surgical Optics provides ophthalmologists with the products and services they need to help improve vision and quality of life for their patients.

For more information about Hoya Surgical Optics, visit www.HOYA.com/SurigalOptics.

About Hoya Corporation
Hoya Corporation is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: The Eye Care provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surgery. The Life Care provides endoscopic system. Electro-Optics makes mask blanks and photomasks for the semiconductor devices and LCD panels, optical lenses for digital cameras, and glass memory disks for HDDs. The Imaging produces SLR/compact digital cameras, interchangeable lenses, lens modules and microlenses. Hoya now has over 80 subsidiaries and affiliates, and employs approximately 38,000 people worldwide.

All statements in this press release that are not statements of historical fact are forward-looking statements, including statements about any of the following: The plans, strategies, and objectives of management for future operations or prospects for achieving such plans; our future performance; statements of belief; and any statements of assumptions underlying any of the foregoing.

iSymm Aspheric Lens included in reduced spherical aberration category for new technology IOLs.

CHINO HILLS, CALIF., JULY 17, 2009— Hoya Surgical Optics today announced that the Centers for Medicare and Medicaid Services (CMS) has added the Blue Light Absorbing iSymm Aspheric Lens from Hoya Surgical Optics to the New Technology Intraocular Lens (NTIOL) class for IOLs with Reduced Spherical Aberration.

The NTIOL designation indicates that the iSymm lens has been proven to provide subset-specific clinical benefits and is approved for $50 additional Medicare payment in conjunction with cataract procedures performed in ambulatory surgical centers under the HCPCS code Q1003.

“I am extremely pleased that CMS has approved the iSymm Lens for NTIOL classification,” says Steve Ziemba, vice president, regulatory affairs, Hoya Surgical Optics. “After careful review of the technology and benefits, CMS recognized that the iSymm lens provides reduced spherical aberration and should be included in this premium IOL category.”

The ruling, which went into effect on April 30th, 2009, and extends until February 26, 2011, applies to Hoya Surgical Optics Blue Light Absorbing Aspheric intraocular lens, model number FY-60AD.

As the fourth largest IOL manufacturer in the world, Hoya Surgical Optics leverages more than 65 years of experience in precision optics technology into the design and manufacture of the iSymm Lens. The Aspheric Balanced Curve Design of the iSymm Lens provides better visual image quality and contrast sensitivity. The hydrophobic material is lathe-cut and tumble-polished to ensure the safety and reliability of Hoya lenses for doctors and their patients. Its unique one-piece design provides a safe and easy insertion experience for doctors. The iSymm Lens portfolio includes the UV-protecting option that addresses the unique needs of patients.

“Our team has moved quickly to ensure that doctors and patients have access to the iSymm Lens technology,” says Tom Dunlap, global president and CEO, Hoya Surgical Optics. “This exemplifies Hoya’s commitment to precision optics leadership. We look forward to continuing to provide leading technologies for our customers.”

About Hoya Surgical Optics
Hoya Surgical Optics is a global leader focused on meeting the needs of surgeons and patients worldwide. As the world’s fourth largest IOL manufacturer and distributor, we are deeply committed to advancing ophthalmic surgery by combining surgeons’ clinical and professional knowledge with our optics research and development. Leveraging more than 65 years of excellence in optics design and innovation that has been the benchmark of the Hoya Corporation, Hoya Surgical Optics provides ophthalmologists with the products and services they need to help improve vision and quality of life for their patients.

CHINO HILLS, CALIF, AND TOKYO, JAPAN, May 12, 2009 — Hoya Corporation announced the appointment of Thomas A. Dunlap, MBA, to the position of Global President and Chief Executive Officer, Hoya Surgical Optics, Inc. (HSO).

“Hoya Corporation is extremely pleased to have Tom Dunlap lead the global division for Hoya Surgical Optics,” said Hiroshi Hamada, COO of Hoya Corporation. “Tom brings a wealth of knowledge, insight and experience from the ophthalmic industry. We expect Tom’s leadership to have a major impact in bringing HSO to a global leadership position.”

With more than 30 years experience as a senior executive in the ophthalmic industry, Mr. Dunlap brings a proven track record in global healthcare firms. He has held executive positions at American Hospital Supply Corporation, Allergan, Inc., and Bausch and Lomb, Inc. He most recently was Executive Vice President of Sand Hill Consulting Associates.

Mr. Dunlap has served in positions with the Outpatient Ophthalmic Surgical Society, ASCRS Foundation, and Ocular Surgery News Industry Advisory Council. He has also been published in the Journal of Administrative Ophthalmology. In addition, he was instrumental in the successful lobbying efforts of the Intraocular Lens Coalition, which led to the establishment of New Technology Intraocular Lens (NTIOL) designation for high technology lens implants.
“I am honored and excited to lead a talented and experienced global team at Hoya Surgical Optics,” Mr. Dunlap says. “Hoya Surgical Optics is the only pure optics company in ophthalmology today. Our precision optics and delivery systems are reflective of the company’s long history of optics excellence. And our pipeline of optics technologies, state-of-the-art manufacturing capabilities, and commitment to serving our customers positions us to be the precision optics leader in ophthalmology for decades to come.”

About Hoya Surgical Optics
Hoya Surgical Optics is a global company focused on meeting the needs of surgeons and patients worldwide. As the world’s fourth largest IOL manufacturer and distributor, we are deeply committed to advancing ophthalmic surgery by combining surgeons’ clinical and professional knowledge with our optics research and development. Leveraging more than 60 years of excellence in optics design and innovation that has been the benchmark of the Hoya Corporation, Hoya Surgical Optics provides ophthalmologists with the products and services they need to help improve vision and quality of life for their patients.

For more information about Hoya Surgical Optics, visit www.HOYA.com/SurgicalOptics.

About Hoya Corporation
Hoya Corporation is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: The Eye Care provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surgery. The Life Care provides endoscopic system. Electro-Optics makes mask blanks and photomasks for the semiconductor devices and LCD panels, optical lenses for digital cameras, and glass memory disks for HDDs. The Imaging produces SLR/compact digital cameras, interchangeable lenses, lens modules and microlenses. Hoya now has over 100 subsidiaries and affiliates, and employs approximately 34,600 people worldwide.

The iSpheric™ Model YA-60BB Intraocular Lens is a foldable hydrophobic acrylic intraocular lens with blue PMMA haptics and a blue-light absorbing yellow optic that absorbs almost all potentially harmful ultraviolet light. The lens can be implanted using an inserter through an un-enlarged phaco incision. In early 2009, HSO plans to introduce a new version of the lens packaged in a sterile, disposable, pre-loaded plastic injector. The iSert™ pre-loaded injector is designed to virtually reduce lens handling time in the operating room and eliminate loading errors that can lead to damaged lenses commonly associated with other foldable IOLs.

HSO expects to begin shipping the current iSpheric™ Intraocular Lenses to surgical facilities throughout the United States later this year.

The iSpheric™ Model YA-60BB Intraocular Lens was evaluated in over 600 clinical study subjects in the FDA clinical trial. Visual acuity results were excellent with over 98% of subjects reporting 20/40 or better Best Corrected Visual Acuity (BCVA) beginning at one month postoperative and maintaining that through the study’s main endpoint, 12 months postoperative. These rates for BCVA exceeded the FDA “Grid” with no lens-related adverse events or significant postoperative complications.
“The iSpheric™ lens has been widely available and well accepted for several years in Japan and Europe,” noted the Medical Monitor for the FDA study, Penny A. Asbell, MD, Professor of Ophthalmology, Director of Cornea and Refractive Services; Mount Sinai School of Medicine, New York, New York, USA, “so the U.S. results are not surprising. The lens is well tolerated and the data from the color-vision sub-study that was part of the FDA trials showed that patients reported no color vision disturbances due to the yellow optic. So, they get additional UV protection without any visual tradeoff.”

“We will begin selling the iSpheric lenses later this year,” reported Yasuro Mori, President of Hoya Surgical Optics, Inc. He added, “We are excited about the upcoming AAO meeting in Atlanta, GA where we can start to introduce ourselves to U.S. surgeons as well as industry professionals interested in working with us as we rapidly build our ophthalmic product portfolio.”

About Hoya Corporation
Hoya Corporation is a global leader in information technology, eye care, medical devices and imaging systems. With over 35,000 employees and operations across the globe, Hoya recorded total sales of over JPY 481.6 billion (US$ 4.37 billion) in fiscal year 2007. Hoya was founded in 1941 and trades on the First Section of the Tokyo Stock Exchange. Hoya Surgical Optics is a subsidiary of Hoya Corporation and has been a worldwide manufacturer and distributor of intraocular lenses for over 20 years.